Targeted therapy for melanoma

A sample of melanoma may be tested for gene changes or other features. If a relevant change is found, a targeted medicine may interrupt signals that melanoma cells use to grow and divide. The result helps guide options; it does not predict exactly how an individual will respond.

Targeted treatment can be discussed when melanoma cannot be removed completely, has returned, or has spread, depending on the test result and your medical history. Other options may include immunotherapy, surgery or radiation. Your team weighs the tumour pattern, previous treatment, other illnesses, medicines and personal priorities.

Ask how to take each dose and what to do if you vomit or forget one. Keep a record of skin changes, fever, diarrhoea, joint or muscle pain, tiredness, vision changes and changes in heartbeat. Bring all medicines and supplements to every review because interactions can alter treatment effects.

Attend planned examinations and blood tests. Your team may monitor the skin, heart, liver, kidneys, eyes and other organs depending on the medicine. Protect treated or sensitive skin from strong sunlight and follow the product-specific advice given by your clinicians.

Contact your oncology team promptly for a spreading rash, severe diarrhoea, yellow skin or eyes, dark urine, marked weakness, new vision problems, palpitations or breathlessness. Seek urgent care for chest pain, collapse, severe breathing difficulty, facial swelling or confusion.

Ask which melanoma feature was found, how reliable the test result is for treatment planning, how the medicine is taken, and how scans or examinations will check its effect. Ask about interactions, sun protection, pregnancy considerations, monitoring tests and the symptoms that require immediate help.